CA
GEHC icon

Clearstead Advisors’s GE HealthCare GEHC Stock Holding History

Clearstead Advisors’s Portfolio GEHC Stock Details GEHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$397K Buy
6,199
+805
+15% +$52.9K ﹤0.01% 831
2026
Q1 		$384K Sell
5,394
-1,203
-18% -$94.9K ﹤0.01% 782
2025
Q4 		$541K Sell
6,597
-128
-2% -$9.97K 0.01% 632
2025
Q3 		$505K Buy
6,725
+336
+5% +$25.1K 0.01% 625
2025
Q2 		$473K Sell
6,389
-284
-4% -$19.8K 0.01% 624
2025
Q1 		$539K Buy
6,673
+940
+16% +$80.8K 0.01% 554
2024
Q4 		$448K Buy
5,733
+257
+5% +$21.8K 0.01% 608
2024
Q3 		$514K Buy
5,476
+2,207
+68% +$185K 0.01% 561
2024
Q2 		$255K Buy
3,269
+625
+24% +$51K ﹤0.01% 737
2024
Q1 		$214K Buy
2,644
+42
+2% +$3.5K 0.01% 455
2023
Q4 		$201K Sell
2,602
-1,565
-38% -$110K 0.01% 454
2023
Q3 		$284K Buy
4,167
+2,116
+103% +$154K 0.01% 496
2023
Q2 		$167K Buy
2,051
+48
+2% +$3.83K 0.01% 453
2023
Q1 		$164K Buy
+2,003
New +$143K 0.01% 421

Other funds holding GEHC

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Clearstead Advisors's GEHC Position: Q2 2026 in Review

Clearstead Advisors increased its GE HealthCare (GEHC) stake by 15% in Q2 2026, buying an estimated $52.9K and bringing the position to 6,199 shares worth $397K. The position accounts for ﹤0.01% of the portfolio, ranked #831.

Clearstead Advisors first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $541K in Q4 2025. 1,223 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Clearstead Advisors held 6,199 shares of GE HealthCare worth $397K as of Q2 2026.
  • Clearstead Advisors bought 805 GE HealthCare shares in Q2 2026, an estimated $52.9K.
  • GE HealthCare made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #831 holding.
  • Clearstead Advisors first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • Clearstead Advisors's GE HealthCare position peaked at $541K in Q4 2025.
  • 1,223 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.